Prevalence of complications in children with chronic kidney disease according to KDOQI

H Wong1, K Mylrea, J Feber

  • 1Department of Pediatrics, Division of Nephrology, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada.

Kidney International
|June 22, 2006
PubMed

Insights

This study analyzed chronic kidney disease (CKD) complications in 366 children. Findings reveal differences in causes and prevalence compared to adults, suggesting guideline modifications for pediatric care.

Area of Science:

  • Pediatric Nephrology
  • Chronic Kidney Disease Research
  • Clinical Guidelines

Background:

  • The Kidney Disease Outcome and Quality Initiative (KDOQI) guidelines for chronic kidney disease (CKD) were established in 2002, primarily based on adult data.
  • The prevalence of CKD complications in pediatric populations remains largely uncharacterized.
  • Understanding these differences is crucial for appropriate pediatric CKD management.

Purpose of the Study:

  • To determine the prevalence of CKD complications across all stages in a pediatric cohort.
  • To compare the causes and complications of CKD in children versus adults.
  • To evaluate the applicability of current KDOQI guidelines to pediatric CKD patients.

Main Methods:

  • A cross-sectional study was conducted on 366 pediatric patients with CKD.
  • Patients were staged according to KDOQI guidelines based on serum cystatin C levels for estimated renal function.
  • Prevalence of complications including hypertension, anemia, proteinuria, metabolic bone disease, and growth failure was analyzed.

Main Results:

  • Uropathies (31%) and glomerular disease (27%) were the leading causes of CKD.
  • High prevalence of complications was observed: hypertension (70.2%), anemia (36.6%), metabolic bone disease (16.9%), and proteinuria (11.5%).
  • Anemia and metabolic bone disease were frequent even in early stages (GFR >60 ml/min/1.73 m2), and growth failure (11.5%) was common.

Conclusions:

  • The study supports KDOQI guidelines for defining and staging pediatric CKD but highlights significant differences from adult data.
  • Pediatric CKD presents unique causes and complication profiles compared to adults.
  • Modifications to KDOQI guidelines are recommended to better address the specific needs of children with CKD.

Related Concept Videos

Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...